SOAK_&_SLEEP_LIMITED - Accounts


Company registration number 05417432 (England and Wales)
SOAK & SLEEP LIMITED
FINANCIAL STATEMENTS
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
PAGES FOR FILING WITH REGISTRAR
SOAK & SLEEP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 9
SOAK & SLEEP LIMITED
BALANCE SHEET
AS AT 25 DECEMBER 2022
25 December 2022
- 1 -
31 December 2022
1 August 2021
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
3
240,847
283,778
Tangible assets
4
34,769
44,291
275,616
328,069
Current assets
Stocks
2,019,042
2,332,094
Debtors
5
506,829
428,630
Cash at bank and in hand
239,733
584,299
2,765,604
3,345,023
Creditors: amounts falling due within one year
6
(3,785,305)
(3,385,844)
Net current liabilities
(1,019,701)
(40,821)
Net (liabilities)/assets
(744,085)
287,248
Capital and reserves
Called up share capital
7
1,300
1,300
Share premium account
999,800
999,800
Profit and loss reserves
(1,745,185)
(713,852)
Total equity
(744,085)
287,248

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 12 April 2024 and are signed on its behalf by:
S A G Smith
Director
Company Registration No. 05417432
SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
- 2 -
1
Accounting policies
Company information

Soak & Sleep Limited is a private company limited by shares incorporated in England and Wales. The registered office is 78 York Street, London, United Kingdom, W1H 1DP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At true25 December 2022 the company has net liabilities of £744,085 (2021 - net assets of £287,248) and net current liabilities of £1,019,701 (2021 - £40,821). The company's ultimate controlling party has indicated they will continue to support the company for the foreseeable future.

 

The accounts are prepared on a going concern basis. The use of the going concern basis of accounting is appropriate because there are no material uncertainties related to events or conditions that may cast significant doubt about the ability of the company to continue as a going concern.

 

Performance in the financial year was severely impacted by economic factors which disrupted supplies sourced from China and India causing delays to stock.This resulted in a significant downturn in sales and delays to strategic plans. Nevertheless, the board are pleased to report a strong underlying trading result and continued long-term growth in 2023/24.

1.3
Reporting period

The financial statements are prepared for the period from 2 August 2021 to 25 December 2022 to be in line with that of the Group. The prior year financial statements were prepared for the period from 2 August 2020 to 1 August 2021. As a result the comparative amounts presented in the financial statements, including the related notes, are not entirely comparable.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue is recognised when goods are delivered to the customer.

1.5
Intangible fixed assets other than goodwill

Intangibles are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
Over the term of the licence
Website Development costs
4 years straight line
SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
1
Accounting policies
(Continued)
- 3 -
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Plant and equipment
25% reducing balance with assets fully depreciated after 48 months

 

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

 

At each reporting date, property, plant and equipment are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If the estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in the income statement.

 

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of impairment is recognised immediately in the income statement.

1.7
Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

 

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

1.8
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
1
Accounting policies
(Continued)
- 4 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.10
Taxation

Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past reporting periods using tax rates that have been enacted or substantively enacted by the reporting date.

    

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against future taxable profits or against the reversal of deferred tax liabilities.

 

Deferred tax is calculated using tax rates that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

 

1.11
Employee benefits

When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

 

1.12
Share-based payments

For equity-settled share-based payments of employees of the company, where the related shares are parent equity, a share based payment expense is allocated to the company which is measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding allocation adjustment is made to reserves as a capital contribution in the company based on the employees of the company that are part of the parents share option scheme.

 

1.13
Leases

Rentals paid under operating leases are charged to the income statement on a straight line basis over the period of the lease.

 

SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
1
Accounting policies
(Continued)
- 5 -
1.14
Government grants

Government grants are in relation to the Coronavirus Job Retention Scheme. Income is recognised in the profit and loss account in the period in which it becomes receivable.

1.15
Foreign exchange

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

2
Employees

The average monthly number of persons (including directors) employed by the company during the 17 month period was:

2022
2021
Number
Number
Total
31
28
3
Intangible fixed assets
Patents & licences
Website Development costs
Total
£
£
£
Cost
At 2 August 2021
39,500
1,081,228
1,120,728
Additions
-
0
160,313
160,313
At 25 December 2022
39,500
1,241,541
1,281,041
Amortisation and impairment
At 2 August 2021
3,071
833,879
836,950
Amortisation charged for the 17 month period
19,389
183,855
203,244
At 25 December 2022
22,460
1,017,734
1,040,194
Carrying amount
At 25 December 2022
17,040
223,807
240,847
At 1 August 2021
36,429
247,349
283,778
SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
- 6 -
4
Tangible fixed assets
Plant and equipment
£
Cost
At 2 August 2021
140,535
Additions
8,521
At 25 December 2022
149,056
Depreciation and impairment
At 2 August 2021
96,244
Depreciation charged in the 17 month period
18,043
At 25 December 2022
114,287
Carrying amount
At 25 December 2022
34,769
At 1 August 2021
44,291
5
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
451
-
0
Corporation tax recoverable
34,445
41,296
Amounts owed by group undertakings
65,503
-
0
Other debtors
406,430
387,334
506,829
428,630
6
Creditors: amounts falling due within one year
2022
2021
£
£
Bank loans and overdrafts
1,433,578
1,538,955
Trade creditors
475,115
611,156
Amounts owed to group undertakings
1,104,998
643,028
Taxation and social security
443,369
419,321
Other creditors
328,245
173,384
3,785,305
3,385,844

The bank loan facility provided by HSBC Bank has been secured with a fixed and floating charge over the current and future assets of the company.

SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
- 7 -
7
Called up share capital
2022
2021
2022
2021
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1,300
1,300
1,300
1,300
8
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Mr James Leigh
Statutory Auditor:
Azets Audit Services
9
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2022
2021
£
£
Within one year
13,167
39,500
Between two and five years
-
0
29,625
13,167
69,125
10
Financial commitments, guarantees and contingent liabilities

At 31 December 2022 the company had commitments to buy:

USD 1,178,877 for £1,003,526 and EUR 32,200 for £28,515.

11
Related party transactions
SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
11
Related party transactions
(Continued)
- 8 -

At the year end included in other debtors was an amount due from a director of £50 (2020 - £112,117). Interest at a rate of 3% per annum has been charged on the overdrawn balance.

 

Husky Oak Limited, a company owning 99.9% of the share capital of the company received £65,503 of services paid for by the company. This balance remains outstanding at period end.

 

The company owed £475,824 to another group member at year end - the loan was provided during the year and includes interest accrued at 10%.

12
Parent company

The immediate parent undertaking is Soak & Sleep Holdings Limited, a company registered in England & Wales with the same registered office as the company.

 

The ultimate controlling party is CVB, INC, A Utah benefit corporation with a registered office of 1525 W 2960 S, Nibley, UT 84321, USA.

 

13
Prior period adjustment
Reconciliation of changes in equity
3 August
1 August
2020
2021
£
£
Adjustments to prior 17 month period
Write off of old balances
-
533,994
Equity as previously reported
(346,347)
(246,746)
Equity as adjusted
(346,347)
287,248
Analysis of the effect upon equity
Profit and loss reserves
-
533,994
Reconciliation of changes in (loss)/profit for the previous financial period
2021
£
Adjustments to prior 17 month period
Write off of old balances
533,994
Loss as previously reported
(223,706)
Profit as adjusted
310,288
SOAK & SLEEP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 17 MONTH PERIOD ENDED 25 DECEMBER 2022
13
Prior period adjustment
(Continued)
- 9 -
Notes to reconciliation
Write off of old balances

During the period a reconciliation was undertaken to tidy up a lot of old creditor and debtor balances that were no longer payable or receivable. This resulted in a net credit to the profit and loss account as detailed above.

 

The effect of this adjustment has resulted in a decrease in administration expenses for the year ended 1 August 2021 of £533,994 and an increase in reserves of £533,994.

2022-12-252021-08-02false16 April 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityThis audit opinion is unqualifiedC HuntMr. S CassarLord S RoseMr. A TuckeyJ D SteedS A G SmithMr J Steedfalse054174322021-08-022022-12-25054174322022-12-25054174322021-08-0105417432core:PatentsTrademarksLicencesConcessionsSimilar2022-12-2505417432core:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-12-2505417432core:PatentsTrademarksLicencesConcessionsSimilar2021-08-0105417432core:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-08-0105417432core:PlantMachinery2022-12-2505417432core:PlantMachinery2021-08-0105417432core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-2505417432core:CurrentFinancialInstrumentscore:WithinOneYear2021-08-0105417432core:CurrentFinancialInstruments2022-12-2505417432core:CurrentFinancialInstruments2021-08-0105417432core:ShareCapital2022-12-2505417432core:ShareCapital2021-08-0105417432core:SharePremium2022-12-2505417432core:SharePremium2021-08-0105417432core:RetainedEarningsAccumulatedLosses2022-12-2505417432core:RetainedEarningsAccumulatedLosses2021-08-0105417432bus:Director52021-08-022022-12-2505417432core:IntangibleAssetsOtherThanGoodwill2021-08-022022-12-2505417432core:PlantMachinery2021-08-022022-12-25054174322020-08-032021-08-0105417432core:PatentsTrademarksLicencesConcessionsSimilar2021-08-0105417432core:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-08-01054174322021-08-0105417432core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2021-08-022022-12-2505417432core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssets2021-08-022022-12-2505417432core:ExternallyAcquiredIntangibleAssets2021-08-022022-12-2505417432core:PatentsTrademarksLicencesConcessionsSimilar2021-08-022022-12-2505417432core:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-08-022022-12-2505417432core:PlantMachinery2021-08-0105417432core:WithinOneYear2022-12-2505417432core:WithinOneYear2021-08-0105417432core:BetweenTwoFiveYears2022-12-2505417432core:BetweenTwoFiveYears2021-08-0105417432bus:PrivateLimitedCompanyLtd2021-08-022022-12-2505417432bus:SmallCompaniesRegimeForAccounts2021-08-022022-12-2505417432bus:FRS1022021-08-022022-12-2505417432bus:Audited2021-08-022022-12-2505417432bus:Director12021-08-022022-12-2505417432bus:Director22021-08-022022-12-2505417432bus:Director32021-08-022022-12-2505417432bus:Director42021-08-022022-12-2505417432bus:Director62021-08-022022-12-2505417432bus:CompanySecretary12021-08-022022-12-2505417432bus:FullAccounts2021-08-022022-12-25xbrli:purexbrli:sharesiso4217:GBP